Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by canadapieton Nov 27, 2018 11:27am

100 Views

Post# 29027373

RE:Spceo

Bucknelly21 - (11/27/2018 10:24:52 AM)
Spceo

Haven’t heard from you in a while or got any emails?

What can he tell?? We are stuck with a product (lifesaving) that doesn't sell like we all had hoped for! Early, that's truth, but it was written that this niche hiv-market was waiting for that product.
Maybe it would better fit with a BP that has a much greater salesforce like Gilead.(it would fit in there hiv port) !

Stille hoping for that "inflection point".......

All the best !

Bullboard Posts

Anaergia expands relationship with PepsiCo